Skip to content
10-K

Annual Report

TONGLI PHARMACEUTICALS (USA), INC.

0001144204-13-037283

← back to feed
Filed
Jun 28, 2013 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2012 · Mar 31, 2013 0 sh
Capex FY 2012 · Mar 31, 2013 $0
Capex FY 2012 · Mar 31, 2012 $871
Operating Cash Flow FY 2012 · Mar 31, 2013 $6.04M
Operating Cash Flow FY 2012 · Mar 31, 2012 −$285.03K
Stockholders Equity FY 2012 · Mar 31, 2013 $20.47M
Stockholders Equity FY 2012 · Mar 31, 2012 $18.34M
Stockholders Equity FY 2012 · Mar 31, 2011 $15M
Current Liabilities FY 2012 · Mar 31, 2013 $1.59M
Current Liabilities FY 2012 · Mar 31, 2012 $1.5M
Current Assets FY 2012 · Mar 31, 2013 $4.07M
Current Assets FY 2012 · Mar 31, 2012 $9.14M
Total Assets FY 2012 · Mar 31, 2013 $22.06M
Total Assets FY 2012 · Mar 31, 2012 $19.84M
Sga Expense FY 2012 · Mar 31, 2013 $875.38K
Sga Expense FY 2012 · Mar 31, 2012 $1.72M
Net Income FY 2012 · Mar 31, 2013 $1.49M
Net Income FY 2012 · Mar 31, 2012 $2.15M
Operating Income FY 2012 · Mar 31, 2013 $2.24M
Operating Income FY 2012 · Mar 31, 2012 $3.3M
Gross Profit FY 2012 · Mar 31, 2013 $5.61M
Gross Profit FY 2012 · Mar 31, 2012 $5.79M
Cost Of Revenue FY 2012 · Mar 31, 2013 $5.5M
Cost Of Revenue FY 2012 · Mar 31, 2012 $9.7M